Pharmaceutical Europe

Pharmaceutical Europe

From the simple pill to the most sophisticated treatment, all medicines manufactured and sold in Europe are subject to strict standards, covering composition, production and quality.

The establishment of a "European Pharmacopoeia" in 1964 marked the first step towards making a unified "pharmaceutical Europe" a reality. Participating states no longer needed to fear that medicines manufactured in the other countries would fall short of their national requirements.

The European Directorate for the Quality of Medicines & HealthCare (EDQM) contributes to the basic human right of access to good quality medicines and healthcare by elaborating quality standards for the manufacture and quality control of medicines in Europe (a European Pharmacopoeia comprising over 2,000 standards) and beyond. It is responsible for the Certification of suitability of European Pharmacopoeia monographs for controlling the quality of substances used in medicines.

From the beginning, the EDQM developed its activities in close collaboration with the European Union and other partner organisations to promote the implementation of a coherent regulatory framework that satisfies public health needs.

Since its creation, the activities of the EDQM were extended to other areas concerning medicines for human and veterinary use. It also enlarged its field of competence with blood transfusions, organ transplantations, standards and coordination of controls for cosmetics and food packaging as well as risk management and prevention of public health risks posed by counterfeit medical products and similar crimes were transferred to the EDQM.

The Council of Europe adopted, on 8 December 2010, a Convention, called "MEDICRIME", to combat counterfeit ant illegal medecines and healthcare products, including those being offered on the web.

Web Content Display

Fighting counterfeit medical products: Council of Europe Medicrime Convention launched

The Council of Europe, the Russian Ministry of Public Health and Social Development and the Federal Service on Surveillance in Healthcare and Social Development (Roszdravnadzor) are looking to give a boost to the fight against counterfeit medical products and similar crimes at .

The Medicrime Convention was opened for signature at a conference in Moscow on 26 to 28 October 2011. Views were exchanged on providing the legislative support and practical measures to relevant bodies, the systems and procedures needed to implement the Convention in practice as part of a country’s domestic legislation. (more...)

Web Content Display

Medicinal products prepared in pharmacies: Committee of Ministers of the Council of Europe adopts a resolution

The Committee of Ministers of the Council of Europe has adopted on 19 January 2011 a Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients. (more...)

Web Content Display

Conference on counterfeit medical products: ''Medication - No falsification'' (15-16 April 2010)

The conference, which took place in Basel (Switzerland), aimed to strengthen the fight against counterfeit medical products and similar crimes in Europe and worldwide by ensuring the necessary support for the implementation of the future MEDICRIME Convention and to encourage international co-operation.

The Convention will be the first instrument to oblige States Parties to criminalise: the manufacturing of counterfeit medical products; supplying, offering to supply and trafficking in counterfeit medical products; the falsification of documents; the unauthorised manufacturing or supplying of medicinal products and the placing on the market of medical devices which do not comply with conformity requirements. The Convention is due to be adopted in 2010. (more...)

Related file